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Abstract
Purpose The purpose of this study was to investigate the fea-
sibility of an online self-management application
(OncoKompas) among cancer survivors. In OncoKompas,
cancer survivors can monitor their quality of life (QOL) via
participant reported outcomes (PROs) (BMeasure^), which is
followed by automatically generated individually tailored
feedback (BLearn^) and personalized advice on supportive
care services (BAct^).
Methods A pretest–posttest design was used, conducting a
survey before providing access to OncoKompas, and 2 weeks
after, followed by an interview by a nurse. Adoption was
defined as the percentage of cancer survivors that agreed to
participate in the study and returned the T0 questionnaire.
Implementation was defined as the percentage of participants
that actually used OncoKompas as intended (T1). General
satisfaction was assessed based on the mean score of three
study-specific questions: (1) general impression of
OncoKompas, (2) the user-friendliness, and (3) the ability to
use OncoKompas without assistance (10-point Likert scales).
Furthermore, satisfaction was measured with the Net
Promotor Scale (NPS).
Results OncoKompas was feasible with an adoption grade of
64 %, an implementation grade of 75–91 %, a mean satisfac-
tion score of 7.3, and a positive NPS (1.9). Sociodemographic
and clinical factors and QOL were not associated with satis-
faction. Several facilitators and barriers related to the feasibil-
ity of OncoKompas were identified.
Conclusion OncoKompas is considered feasible, but has to be
further improved. In order to enhance feasibility and increase
satisfaction, we have to balance the time it takes to use
OncoKompas, measurement precision, and tailoring towards
personalized advices.
Keywords Neoplasms . Self-management . EHealth .
Supportive cancer care . Quality of life . Lifestyle
Introduction
Cancer and cancer treatment have a large impact on quality of
life (QOL). Head and neck cancer (HNC) has a specific im-
pact on survivors. In addition to symptoms such as fatigue,
HNC survivors are confronted with oral dysfunction, speech
and swallowing problems, and related social withdrawal and
psychological distress. All of these symptoms can deteriorate
quality of life [1, 2] and increase survivors’ needs for support-
ive care services. Several recent papers report on the need for
improving survivorship cancer care [3, 4] to enhance quality
of life and diminish societal discrimination.
It is essential that cancer survivors have access to optimal
supportive care services including self-management options.
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Access to supportive care may be hampered by current chang-
es in the health care system, e.g., limited time of health care
providers and centralization of care [5]. To improve accessi-
bility, cancer survivors are expected to adopt an active role in
managing their own care. Self-management is defined by
McCorkle et al. [6] as Bthose tasks that individuals undertake
to deal with the medical, role, and emotional management of
their health condition(s).^ Alongside usual care, self-
management options can be (cost-)effective and improve
quality of life [3]. Although there is evidence that supportive
cancer care can be effective, referral rates are low and many
survivors have unmet needs. Innovating supportive cancer
care includes incorporation of self-management and eHealth,
implementation of evidence-based approaches to monitor
QOL [7, 8], and redesign of the organization of supportive
care according to participant centered models of care (e.g.,
the chronic care model, disease management, and stepped
care) [3, 7, 9].
We developed an eHealth application BOncoKompas^with
the aim to facilitate and innovate the access to supportive
cancer care. In OncoKompas, cancer survivors can monitor
their QOL by means of participant reported outcomes (PROs)
(BMeasure^), which is followed by automatically generated
tailored feedback (BLearn^) and personalized advice on sup-
portive care services (BAct^). To ensure sustainable imple-
mentation of OncoKompas, we followed participatory design
principles. Cancer survivors and health care professionals
(HCPs) were involved in each step of the development pro-
cess [10–12] (Fig. 1). A qualitative assessment of needs
among cancer survivors and HCPs (step 1) showed that cancer
survivors are interested in an eHealth application that targets
personalized access to supportive care and that HCPs expect
that an eHealth application could optimize survivorship care
[13]. A prototype of the eHealth application, BOncoKompas^,
was developed. Existing applications were used as examples
to build the application [14, 15]. OncoKompas was developed
together with mixed teams consisting of cancer survivors and
medical specialists as well as allied health professionals. In
step 2, the usability of a prototype was tested among both
cancer survivors and HCPs, targeting system quality (ease of
use), content quality (usefulness and relevance), and service
quality (the process of care provided) [16, 17]. HCPs raised
several points for improvement regarding the ease of use and
usefulness of the application, resulting in improved persua-
siveness and improved tailoring. Usability tests among cancer
survivors identified some weaknesses in the user interface that
resulted in adjustments, e.g., clearer user instructions [18].
Based on these findings, the prototype of OncoKompas was
optimized. The next step (step 3) in the developmental cycle
of OncoKompas is to investigate the feasibility in clinical
practice.
The purpose of the present study was to investigate the
feasibility of OncoKompas: adoption (intent to use
OncoKompas), usage (actual use of OncoKompas), and satis-
faction with OncoKompas among cancer survivors.
Secondary aims were to investigate which sociodemographic
and clinical factors are associated with the feasibility of
OncoKompas and to obtain insight in possible barriers and
facilitators of the feasibility of OncoKompas.
This feasibility study will provide insight into factors that
contribute to the development and usage of eHealth applica-
tions among head and neck cancer survivors.
Methods
A pretest-posttest design was used, conducting a survey be-
fore providing cancer survivors access to OncoKompas (T0)
and 2 weeks after (T1). After participants completed the T1
survey, they were interviewed by a nurse specialized in oncol-
ogy to obtain more in-depth insight into the feasibility of
OncoKompas.
Study sample and procedures
Between January and July 2013, all eligible cancer survivors
from the Departments of Otolaryngology-Head and Neck
Surgery from VU University Medical Center, Amsterdam,
University Medical Center Leiden, and University Medical
Center Maastricht, The Netherlands were invited by an oncol-
ogy nurse or head and neck surgeon. Participants were eligible
if they (1) were treated for head and neck cancer with curative
intent with a maximum of 2 years prior, (2) were
18 years or older, (3) were able to write, read, and speak
Dutch, (4) had some Internet experience, and (5) had access
to the Internet at home.
Semi-structured interviews cancer 
survivors  
Prototype OncoKompas 1.0 
Usability study cancer survivors 
Resulted in 
Prototype OncoKompas 1.1 
Resulted in 
Cognitive walkthrough HCPs 
Semi-structured interviews HCPs 
Feasibility study OncoKompas 1.1 
Fig. 1 Flow chart development process OncoKompas based on
participatory design principles
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If participants agreed to participate, they were asked to com-
plete and return a paper-and-pencil questionnaire (T0).
Subsequently, participants were contacted to provide themwith
a login code for OncoKompas at home. An interview was
scheduled with an oncology nurse from their hospital 2 weeks
later. Prior to their appointment with the nurse, cancer survivors
were asked to fill in the post-test questionnaire (T1). During the
consultation with the nurse, attention was paid to perceived
usefulness of the tailored advice and personalized referral to
supportive care services, as provided by OncoKompas.
Oncology nurses made standardized interview reports. The
scheme consisted of twomain components: part A for survivors
who completed OncoKompas and part B for survivors who did
not complete Oncokompas. Key questions included in part A
comprise the following: (1) BHow would the survivor describe
their experience with OncoKompas?^, (2) BDid the survivor
view their personalized advice and supportive care options? If
not, why?^, and (3) BDid the survivor find the results applicable
to their personal situation?^. Key questions included in part B
comprise the following: (1) Why did the survivor not complete
OncoKompas?^, (2) BWhat should be changed in the applica-
tion to enable the survivor to complete OncoKompas?^, and (3)
BWhat aspects did the survivor miss in OncoKompas that
prevented the survivor to complete the application?^. Nurses
completed the scheme during the consultation with the survi-
vors and supplemented these following the consultation.
Technical support was offered by two researchers (SL and
FJ) when problems occurred with the access or use of
OncoKompas. The researchers recorded an entry in a logbook
with each technical problem.
The study was conducted according to regular procedures
of the local ethical committee of the VU University Medical
Center, Amsterdam. All participants signed informed consent.
Intervention BOncoKompas^
OncoKompas can be considered as both a screening and a
monitoring tool and consists of three components: (1) mea-
sure, (2) learn, and (3) act. In the BMeasure^ component, can-
cer survivors can independently complete PROs targeting the
following QOL domains: physical functioning, psychological
functioning, social functioning, healthy lifestyle, and existen-
tial issues. Besides these domains for cancer survivors in gen-
eral, a specific domain, containing topics for head and neck
cancer patients, is allocated (Table 1). Specific PROs were
selected by the project team in collaboration with teams of
experts, based on Dutch practice guidelines and literature
searches. Data from the BMeasure^ component are processed
in real-time and linked to tailored feedback to the cancer sur-
vivor in the BLearn^ component. All algorithm calculations
are based on available cut-off scores, or they are defined based
on Dutch practice guidelines, literature searches, and/or con-
sensus by teams of experts. In the BLearn^ component, a com-
pass metaphor is used to summarize overall well-being.
Following this, feedback is provided to the participant on the
level of the topics (e.g., depression and fatigue) by means of a
three-color system: green (no elevated well-being risks), or-
ange (elevated well-being risks), and red (seriously elevated
well-being risks) (first-degree algorithms). Cancer survivors
receive elaborated personalized information on the outcomes,
e.g., on the topic depression, information is provided on the
symptoms of depression and the proportion of cancer survi-
vors who suffer from depressive symptoms.
Special attention is paid to clusters of interrelated symp-
toms. For example, feedback on the association between de-
pression and fatigue is provided, if a participant has an orange
or a red score on depression as well as on fatigue. The
Table 1 Overview of topics OncoKompas
Psychological quality
of life
Physical quality of life Social quality of life Healthy lifestyle Life questions Head and neck cancer
Anxiety and depression General everyday life Social life Alcohol Life questions Swallowing
Fear of recurrence Pain Relationship with partner Physical activity Speech
Subjective cognitive
functioning
Sexuality Relationship with children Dietary intake Oral function
Stress Sleep quality Financial circumstances Weight Neck and shoulder function
Body image Patient–physician communication Smoking Loss of smell and taste
Fatigue Return to work Head and neck cancer specific
lymphedema
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feedback in the BLearn^ component concludes with a compre-
hensive self-care advice (tips and tools). All these advices are
tailored to the individual cancer survivor (second-degree
algorithms).
In the BAct^ component, survivors are provided with
personalized supportive care options, based on their
PRO scores and expressed preferences (e.g., preference
for individual therapy versus group therapy) (third-de-
gree algorithms). If a participant has elevated well-
being risks (orange score), the feedback includes sug-
gestions for self-help interventions. If a participant has
Bseriously elevated well-being risks^ (red score), the
feedback includes an advice to contact their own medi-
cal specialist or general practitioner.
In appendix 1, a worked example of OncoKompas using a
case study is presented. For a clickable demo of the applica-
tion (in Dutch) or an animation video (in Dutch and English),
please visit www.oncokompas.nl.
Outcome measures
A study-specific survey was composed with items on
sociodemographic and clinical factors, a QOL questionnaire
(assessed at baseline (T0)), and items on usage and satisfac-
tion (assessed at follow-up (T1)).
Adoption, usage, and satisfaction
Adoption was defined as the percentage of cancer survivors
that agreed to participate in the study and returned the T0
questionnaire and informed consent.
Usage was defined as the percentage of participating
cancer survivors that actually used OncoKompas as
intended based on the item BDid you fill out and use
OncoKompas?^ (T1).
General satisfaction was assessed based on the mean score
of three study-specific questions: general impression of
OncoKompas, the user-friendliness, and the ability to use
OncoKompas without assistance (10-point Likert scales: 0
(poor) to 10 (good)). Furthermore, satisfaction was measured
with the Net Promoter Score (NPS) with the question BHow
likely it is that you would recommend OncoKompas to other
cancer survivors (10-point Likert scale: 0 (not likely) to 10
(very likely)). The NPS was calculated by dividing the per-
centage of promoters (who score 9–10) minus the percentage
of detractors (who score 0–6). The percentage Bpassives^
(who score 7–8) is not included in calculating NPS. The
NPS ranges between −100 and +100. A positive score is con-
sidered good [19].
Additionally, the satisfaction of participants on the three
components of OncoKompas was assessed (measure, learn,
and act).
Moderating factors
Sociodemographic (age and gender) and clinical variables (tu-
mor location, tumor stage, type of treatment, and comorbidity)
were drafted by a physician from the medical records.
Comorbidity was assessed by the use of the Adult
Comorbidity Evaluation 27 (ACE-27), a validated chart built
instrument, resulting in a total comorbidity score of none,
mild, moderate, or severe [20].
The 30-item EORTC QLQ-C30 (version 3.0) includes a
global health-related quality of life (HRQOL) scale (two
items) and five functional scales: physical functioning, role
functioning, emotional functioning, cognitive functioning,
and social functioning. There are three symptom scales (nau-
sea and vomiting, fatigue, and pain) and six single items re-
lating to dyspnea, insomnia, loss of appetite, constipation,
diarrhea, and financial difficulties. In the present study, the
HRQOL scale was used. The scores of the QLQ-C30 are
linearly transformed to a scale of 0–100, with a higher score
indicating a higher level of HRQOL [21].
Facilitators and barriers
After the participants completed the T1 survey, they were
interviewed by an oncology nurse to obtain more in-depth
insight into barriers and facilitators of the feasibility of
OncoKompas.
To evaluate technical issues interfering with the feasibility
of OncoKompas, the entries in the helpdesk logbook were
evaluated on the type of problem encountered, and if and
how the problem was solved.
Data analyses
Descriptive statistics were used to summarize the adoption,
usage, and satisfaction. OncoKompas was defined feasible
in case of an adoption and usage grade of more than 50 %, a
mean satisfaction score of at least 7, and a positive Net
Promoter Score. This definition of feasibility is based on
adoption and usage rates reported in previous studies on
eHealth applications [22].
Correlations between satisfaction with OncoKompas and
gender (male vs. female), age (<65 vs. >64 years), comorbid-
ity (none/mild vs. moderate/severe), tumor subsite (oral
cavity/oropharynx vs. hypopharynx/larynx vs. other), tumor
stage (stage I/II vs. stage III/IV), and treatment modality (sur-
gery alone vs. surgery plus (chemo)radiation vs. (chemo)radi-
ation) were examined using chi-square tests. The outcome
variable satisfaction with OncoKompas was not normally dis-
tributed and was therefore dichotomised into two categories: a
score from 0 to 6 and a score of 7 and higher. The association
between satisfaction with OncoKompas and QOL was ana-
lyzed using Mann-Whitney U tests. Statistical analyses were
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performed using the Statistical Package for the Social
Sciences (IBM SPSS Statistics 20). For all analyses, p values
<0.05 (two-tailed) were used as criterion for statistical
significance.
The structured interview reports by the oncology nurses
were analyzed by thematic analyses. Barriers and facilitators
towards feasibility of OncoKompas were extracted from the
reports and those that were mentioned at least five times are
reported. The entries in the logbook with technical difficulties
were categorized by type of problem that was encountered.
The number of unique problems was counted.
Results
Adoption and usage
In total, 106 HNC survivors were asked to participate in the
study. The adoption grade was 64%: 68 out of 106 intended to
use OncoKompas and gave informed consent and returned the
T0 survey. Reasons for non-consent included a lack of time of
the patient and no willingness to travel to the hospital for the
nurses’ consultation.
In total, 12 participants dropped out during the study
(17.6 %), leaving a study cohort of 56 participants (Table 2).
The reasons for dropout included cancer recurrence (n = 2),
entering palliative care (n = 2), family circumstances (n = 1),
comorbid illness (n = 1), tiredness due to which OncoKompas
could not be used (n = 1), evaluating the questions in
OncoKompas as too confronting (n = 1), insufficient Internet
skills according to the participant (n = 1), and not able to reach
participants by telephone (n = 3). Of the 56 participants (56
out of 68) who completed the study, 51 survivors filled out
OncoKompas completely and as intended (usage grade
91 %). In total, five of these participants indicated that
they received assistance while filling out OncoKompas
(with the help of my spouse (N = 4) or with the help of
my daughter (N = 1)). Two survivors indicated to have
used OncoKompas partially (3.6 %). They mentioned
that they only filled out the ‘Measure’ component in
OncoKompas. Three other survivors (5.4 %) indicated
not to have used OncoKompas due to technical reasons;
one participant indicated to be hindered by a bug when
using the application, while the other two participants
indicated that because of a bug in the application they
could not continue. Of the participants who encountered
technical problems, one survivor contacted the helpdesk.
Despite provision of assistance, this participant was not
able to complete OncoKompas. Usage grade thus lies between
75 % (51 out of 68 participants (including dropouts)) and
91 % (51 out of 56 participants (excluding dropouts)) who
used OncoKompas as intended.
Satisfaction
Most of the participants were satisfied with OncoKompas in
general (60.4 %, mean score 6.8, SD 1.2). Participants evalu-
ated OncoKompas as user-friendly (76.0 %, mean score 7.1,
SD 1.6). Participants were able to use OncoKompas without
assistance (90.6 %, mean score 7.8, SD 1.7). The mean satis-
faction score was 7.3 (SD 1.5). The Net Promoter Score of
OncoKompas was positive 1.9, consisting of 21 % promoters,
19 % detractors, and 60 % passives.
Regarding the feasibility of the BMeasure^ component, al-
most all participants answered all PROs (98 %). For some
participants, the PROs were intrusive (21 %), confusing
(29 %), or difficult to answer (37 %). Confusing and difficult
questions mentioned by survivors included questions related
to God and religion. Questions about sexuality were found
intrusive. Almost all participants (94 %) viewed their well-
being profile in the BLearn^ part of OncoKompas. To most
Table 2 Demographic and health characteristics of the participating






Mean (SD) 59.05 (9.85)
Minimum 25
Maximum 77
Tumor site (n, %)
Oral cavity and oropharynx 30 53.6
Hypopharynx and larynx 12 21.4
Other 14 25.0





Type of treatment (n, %)
(Chemo) radiation therapy ((C)RT) 27 48.2
Surgery 13 23.2
Surgery + (C)RT 16 28.6
Time since treatment (in months)
Mean (SD) 12.32 (6.5)
Minimum 0
Maximum 24
Quality of Life (EORTC QLQ C-30)
Mean (SD) 76.33 (16.49)
Minimum 33.33
Maximum 100
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participants, the description of their results was clear and un-
derstandable (84 %) and easy to find in the application (81%).
More than half of the participants evaluated the information as
applicable to themselves (61 %), but less than half evaluated
the information of added value for their own health status
(43 %). More than half of the participants (61 %) indicated
that the overall picture regarding their results (the compass
metaphor) did not add much. Most participants viewed their
personalized advices (71%), and these advices were evaluated
as clear (85 %) and complete (68 %). The amount of support-
ive care options provided in the BAct^ component was con-
sidered to be exactly right to most participants (71 %) or too
much (23 %). More than half of the participants (57 %) indi-
cated to be interested in one or more of the offered supportive
care options and almost a third of these participants subse-
quently did take action accordingly (29 %). The majority in-
dicated to return to OncoKompas in the future to view their
personalized advices and actions once again (71 %).
The helpdesk was contacted for a total of 21 unique prob-
lems. The problems mainly consisted of difficulties logging
on to the application: due to a browser problem (n = 2), loss of
password (n = 2), expiration of security certificate of the ap-
plication (n = 3), use of a tablet (n = 2), blockage by firewall
(n = 2), no compliance of the computer with application re-
quirements (n = 1), and other reasons (n = 5). Furthermore, an
error message appeared (n = 2) and the button to print the
results was not visible (n = 2).
Factors associated with satisfaction with OncoKompas
Satisfaction with OncoKompas was not significantly associ-
ated with age (X2 (1, N = 53) = 0.26, p = 0.61), gender (X2 (1,
N = 53) = 0.58, p = 0.45), tumor location (X2 (2,
N = 53) = 5.49, p = 0.06) , tumor s tage (X2 (1,
N = 53) = 0.00, p = 0.97), type of treatment (X2 (2,
N = 53) = 3.38, p = 0.19) , comorbidi ty (X2 (1,
N = 53) = 0.034, p = 0.85), and HRQOL (p = 0.35).
Barriers and facilitators
In total, seven barriers towards the feasibility of OncoKompas
were mentioned at least five times (Table 3): (1) The applica-
tion did not fully take into account other diseases that partic-
ipants suffered from, (2) the amount of information in the
application was too much, (3) items regarding existential is-
sues were difficult to answer and too much oriented towards
religion, (4) participants did not find the results completely
applicable to their personal situation (they experienced their
symptoms in a different way), (5) participants found a lapsed
time of 2 years since treatment to introduce the application too
long (these participants often already found a solution to the
experienced problems or learned to live with them), (6) the
description of participant’s overall well-being was suboptimal,
either considered confronting or meaningless, and (7) partici-
pants found some items in the application confusing making it
difficult to answer them truthfully.
Six facilitators were mentioned at least five times (Table 3):
(1) the user-friendliness of the application, (2) it’s informative
nature, (3) the provision of a clear overview to the participant
of their personal situation and options, (4) the clarity of the
items in the questionnaire, (5) the usefulness of the application
in general, and (6) the particular usefulness of the application
for participants who are very ill or experience many symptoms.
Discussion
The aim of this study was to investigate the feasibility of the
eHealth application OncoKompas aiming to facilitate and in-
novate cancer survivorship care. Our results show that
OncoKompas is feasible with an adoption grade of 64 %, a
Table 3 Barriers and facilitators (mentioned at least five times)
Barriers No. of times
mentioned
Facilitators No. of times
mentioned
The application did not fully take into account other
diseases that participants suffered from
11 The user-friendliness of the application 13
The amount of information in the application was too much 9 The informative nature of the applications 7
Items regarding existential issues were difficult to answer
and too much oriented towards religion
9 The provision of a clear overview to the participant of their
personal situation and options
6
Participants did not find the results completely applicable
to their personal situation.
8 The clarity of the items in the questionnaire. 6
Participants found a lapsed time of 2 years since treatment
to introduce the application too long
7 The usefulness of the application in general 5
The description of participant’s overall well-being was
suboptimal
6 The particular usefulness of the application for participants
who are very ill or experience many symptoms
5
Participants found some items in the application confusing
making it difficult to answer them truthfully.
6
2168 Support Care Cancer (2016) 24:2163–2171
usage grade between 75 and 91%, a mean satisfaction score of
7.3, and a positive Net Promoter Score. Almost all participants
were able to use OncoKompas. The few participants that were
not able to use OncoKompas seemed to be hindered by insuf-
ficient eHealth skills. These findings are in line with previous
studies that examined the feasibility of eHealth applications in
clinical practice showing that eHealth applications are accept-
able to many participants but not to all [23–26].
Our study showed no associations with sociodemographic
factors. Also in previous studies, no significant associations
between use of eHealth and gender were found [25, 27, 28].
Previous studies revealed mixed results concerning the asso-
ciation between age and use of eHealth applications [25–29].
Increased age seems to be associated with less use of the
Internet, although this association has become less strong in
recent years, probably due to the availability and increased
familiarity of Internet [26]. A review by Or and Karsh re-
vealed that most studies did not show significant relationships
between eHealth acceptance and age [25]. Our study results
match these findings.
In our study, there were no significant associations between
satisfaction with OncoKompas and clinical factors or QOL.
Previous studies that focused on health and treatment factors
showed that participants who use eHealth are healthier than par-
ticipants who do not use eHealth [30, 31]. A better health status
seems to lead to a better acceptance of Internet applications [32].
However, in other studies, the opposite was found [33, 34].
Other factors than sociodemographic and clinical factors and
QOL may be of more interest in investigating why participants
use (or not use) eHealth applications. Adoption rate of eHealth
can be predicted by the way an eHealth application is rated in
terms of usefulness and ease of use, and the self-efficacy of
participants regarding information technology [25, 35]. In the
present study, only participants with sufficient (self-reported)
computer skills were included. Facilitators associated with the
feasibility of OncoKompas included the user-friendliness of the
application and its informative nature. Ease of use was also de-
termined in previous studies as an important factor for the accep-
tance of eHealth applications [25]. Important barriers included
the feeling that the results did not completely reflect the personal
situation, the large amount of information in the application, and
difficulties answering some of the items. The barrier regarding
the time investment required to complete the application has been
reported in previous studies as well. Length and informa-
tion overload have been found to be important reasons to quit
using an online application [36–38]. Individualized feedback
has been found to be related to sustained intervention use and
less dropout [39, 40].
The strength of our study is that we used mixed methods,
providing in-depth insight into the feasibility of eHealth ap-
plications in clinical practice.
In the present study, only participants were included with
access to the Internet at home. Therefore, we do not have good
insight into the representativeness of our study sample. The
positive attitude of participants towards OncoKompas might
not be generalizable to all HNC survivors. Another limitation
concerns the small sample size, which may have hampered
testing the associations. Finally, in this study, participants had
access to the eHealth application for only 2 weeks. Further
research is needed on the feasibility in the longer term.
Conclusions
OncoKompas is considered feasible, but our results also show
that improvements can be made to enhance the feasibility and
increase the satisfaction among cancer survivors. The PROs can
be further investigated and possibly be reduced. It is also impor-
tant to look at the phrasing of individual items, because of the
barrier that answering some of the items was difficult to partici-
pants. However, in order to ensure accuracy of the individualized
feedback, we have to balance the time it takes to use
OncoKompas, measurement precision, and tailoring towards a
personalized tool. It is clear that any eHealth application will not
be suitable for all participants, due to different needs, preferences,
and coping styles of cancer survivors. It is worthwhile to obtain
more insight into how further tailoring of eHealth applications
and more sophisticated marketing strategies can be applied lead-
ing to applications that are attractive to more participants and
hereby increase adoption and usage.
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Appendix 1: The flow of OncoKompas To provide more
insight into how OncoKompas works, the flow of OncoKompas is pre-
sented to illustrate the successive steps a user takes in OncoKompas that
lead him or her to personalized supportive care options.Wewill use a case
study to make the OncoKompas components comprehensible and pro-
vide insight into the way the responses of users to the PROs lead to
personalized advice. This case study concerns a 49-year old female head
and neck cancer survivor named Mary. She has finished treatment for
laryngeal cancer 6 months prior to using OncoKompas. She is married
and has two children.
Login When entering OncoKompas for the first time, a user is re-
quested to create an account to login. Mary is asked to provide her
personalia, date of birth, and e-mail address.
Measure After the login phase of OncoKompas is completed, a user
enters the BMeasure^ component. In this component, users are presented
with PROs targeting the following quality of life domains; physical
functioning, psychological functioning, social functioning, lifestyle, and
existential issues, completed with a tumor-specific domain containing
specific PROs for head and neck cancer survivors. Users are asked to
complete all PROs. The PRO system consists of dynamic questionnaires.
This means that the system automatically determines whether sequence
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questions are appropriate. In our case study, Mary’s answers to the
screening questions regarding sexual functioning (i.e. ‘Are you willing to
answer questions regarding your sexuality?^, BHave you been sexually
active?^, BHave you experienced problems while being sexually active?^)
and mood result in the provision of elaborated questionnaires (Female
Sexual Function Index (FSFI)1 and the Hospital Anxiety and Depression
Scale (HADS))2 on these topics. In her answers to the FSFI, Mary indi-
cates that she experienced almost no sexual desire in the past 4 weeks and
is dissatisfied with her sexual relationship and emotional bond during
sexual intercourse with her husband. On the HADS, she indicates that she
finds it difficult to enjoy the things she used to enjoy, does not feel
cheerful, and has trouble to laugh and see the funny side of things.
Learn When the PROs are completed, the data from the BMeasure^
component are processed in real-time and linked to tailored feedback to
the user in the BLearn^ component. All algorithm calculations are based
on available cut-off scores or are defined based on Dutch practice
guidelines, literature searches, and/or consensus by teams of experts.
Feedback is provided to the user on the levels of the addressed topics in
the PROs (e.g., sexual problems), bymeans of a three-color system: green
(no elevated well-being risks), orange (elevated well-being risks), and red
(seriously elevated well-being risks) (first-degree algorithms).
In our case study, Mary receives an Borange^ score on sexual func-
tioning, since her score on the FSFI was less than 26.55 (cut-off score for
an orange profile)3. She receives a Bred^ score regarding her mood, be-
cause her score on the depression subscale of the HADS is 10 (cut-off
score for a red profile ≥8)4. When Mary wants to read elaborated person-
alized information about her well-being risks on a specific topic, e.g.,
sexual functioning, she can do so by mouse clicking the topic. This will
enable her to read more information about how sexual problems can arise
after cancer treatment, and how these may influence her quality of life.
The elaborated information is followed by specific attention for clus-
ters of interrelated symptoms. In Mary’s case, she suffers from depressive
symptoms, which could be related to her sexual problems. Therefore, the
user is provided with feedback on the possible interrelation between his or
her symptoms. For Mary, this information consists of how her depressive
symptoms may influence her libido or may negatively impact the way she
experiences sex. She also receives information about how her depressive
symptoms may be influenced by her sexual problems, e.g., frustration to
accept changes regarding sexuality due to cancer (treatment), relationship
problems, or a feeling of inferiority caused by her sexual problems.
The feedback in the BLearn^ component concludes with comprehen-
sive self-care advice (tips and tools). All these advices are tailored to the
individual user (second-degree algorithms). In our case study, Mary is
provided with a brochure about sexuality and cancer from the Dutch
Cancer Society, combined with the advice to select a supportive care
option from the BAct^ component to address her sexual problems.
Act After finishing the BLearn^ component, users are automatically
directed to the BAct^ component. In this component of OncoKompas,
users are provided with personalized supportive care options, based on
their PRO scores and expressed preferences (e.g., preference for indi-
vidual therapy versus group therapy) (third-degree algorithms). If a par-
ticipant has elevated well-being risks (orange score), the feedback in-
cludes suggestions for (guided) self-help interventions. If a participant has
Bseriously elevated well-being risks^ (red score), the feedback includes
an advice to contact their ownmedical specialist or general practitioner. In
Mary’s case, she is provided with three supportive care options regarding
her sexual functioning: the possibility of online sex therapy (e.g., via
mental health care providers that offer internet therapy), the website of the
Rutgers Nisso group (www.seksualiteit.nl) that provides tips and online
self-help exercises to cope with problems regarding sexual functioning
and has a specific information section regarding sexual functioning after
cancer treatment, and the website of the Dutch Society of Sexology
(www.nvvs.info) that provides elaborated information regarding
problems with sexual functioning and what the role of a sexual therapist
entails. Also, three alternative supportive care options are provided: the
advice to contact her treating physician, her general practitioner, or a
sexual therapist. Regarding her depressive symptoms, she is also advised
to contact her physician or her general practitioner and is able to mouse
click a link to a website that has a list of psychologists specialized in
oncology to make a well informed choice. If a user wishes to do so, he or
she is able to print their OncoKompas results and bring these with them to
their physicians consultation.
1 Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R
et al., Ferguson D, D’Agostino R Jr. The Female Sexual Function
Index (FSFI): a multidimensional self-report instrument for the as-
sessment of female sexual function. J Sex Marital Ther 2000;
26(2):191–208.
2 Zigmond AS, Snaith RP: The hospital anxiety and depression scale.
Acta Psychiatr Scand 1983, 67: 361–370.
3 Wiegel M, Meston C, Rosen R., The female sexual function index
(FSFI): cross-validation and development of clinical cutoff scores.
4. Bjelland, I., Dahl, A. A., Haug, T. T., &Neckelmann, D. (2002). The
validity of the Hospital Anxiety and Depression Scale: An updated
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